News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Molecular Response (MRL) and Scripps Genomic Medicine Announce Joint Discovery/Development Agreement


6/1/2011 9:02:04 AM

Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today a joint discovery/development agreement with Scripps Genomic Medicine that will advance research in the areas of oncology and cardiovascular disease.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES